Given the presence of early-onset seizures, developmental delay, microcephaly, and progressive spasticity, genetic testing was performed, revealing a pathogenic variant in SLC2A1, confirming a diagnosis of GLUT1 deficiency syndrome (GLUT1-DS). This evidence concerns the gene SLC2A1 and Global developmental delay.